
Omega Therapeutics Inc Investor Relations Material
Latest events

Study Update
Omega Therapeutics Inc
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Omega Therapeutics Inc
Access all reports
Omega Therapeutics Inc. is a clinical-stage biotechnology company focused on developing a new class of programmable epigenomic mRNA medicines. The company's OMEGA platform enables precise control of gene expression without altering native nucleic acid sequences, aiming to address the root causes of various diseases. Omega's therapeutic candidates target a range of conditions, including oncology, regenerative medicine, and multigenic and monogenic diseases. Founded in 2017 by Flagship Pioneering, Omega Therapeutics is headquartered in Cambridge, Massachusetts, and its shares are listed on the NASDAQ.
Latest articles
)
Moncler: From the Mountains to the Runway
The story of Moncler, all the way from its beginnings in the Alps to its journey to some of the most prestigious runways in the world.
16 Apr 2025
)
eToro: Innovation, Growth, and IPO Plans
eToro was founded in 2007 and has grown into a global trading platform with over 40 million users and an extensive offering across several asset classes.
10 Apr 2025
)
Yum! Brands: The Company Behind Pizza Hut, KFC, and Taco Bell
Yum! Brands started at PepsiCo in the 1970s and is home to some of the most well-known brands in the world, such as Pizza Hut, KFC, and Taco Bell.
9 Apr 2025
Ticker symbol
OMGA
Country
🇺🇸 United States